In a recent study by Green et al (2008), immunohistochemical analyses of tissue microarrays have indicated that moderate/high levels of NCOR2 protein, as found in 16.7% of tumours, are associated with poor prognosis of breast cancer patients. Here, NCOR2 is linked to breast carcinoma.